Literature DB >> 28807916

Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.

Wen Dang1, Yuebang Yin1, Yijin Wang1, Wenshi Wang1, Junhong Su2, Dave Sprengers1, Luc J W van der Laan3, Krzysztof Felczak4, Krzysztof W Pankiewicz4, Kyeong-Ok Chang5, Marion P G Koopmans6, Herold J Metselaar1, Maikel P Peppelenbosch1, Qiuwei Pan7.   

Abstract

Norovirus is a major cause of acute gastroenteritis worldwide and has emerged as an important issue of chronic infection in transplantation patients. Since no approved antiviral is available, we evaluated the effects of different immunosuppressants and ribavirin on norovirus and explored their mechanisms of action by using a human norovirus (HuNV) replicon-harboring model and a surrogate murine norovirus (MNV) infectious model. The roles of the corresponding drug targets were investigated by gain- or loss-of-function approaches. We found that the calcineurin inhibitors cyclosporine (CsA) and tacrolimus (FK506) moderately inhibited HuNV replication. Gene silencing of their cellular targets, cyclophilin A, FKBP12, and calcineurin, significantly inhibited HuNV replication. A low concentration, therapeutically speaking, of mycophenolic acid (MPA), an uncompetitive IMP dehydrogenase (IMPDH) inhibitor, potently and rapidly inhibited norovirus replication and ultimately cleared HuNV replicons without inducible resistance following long-term drug exposure. Knockdown of the MPA cellular targets IMPDH1 and IMPDH2 suppressed HuNV replication. Consistent with the nucleotide-synthesizing function of IMPDH, exogenous guanosine counteracted the antinorovirus effects of MPA. Furthermore, the competitive IMPDH inhibitor ribavirin efficiently inhibited norovirus and resulted in an additive effect when combined with immunosuppressants. The results from this study demonstrate that calcineurin phosphatase activity and IMPDH guanine synthase activity are crucial in sustaining norovirus infection; thus, they can be therapeutically targeted. Our results suggest that MPA shall be preferentially considered immunosuppressive medication for transplantation patients at risk of norovirus infection, whereas ribavirin represents as a potential antiviral for both immunocompromised and immunocompetent patients with norovirus gastroenteritis.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  calcineurin inhibitors; cell culture; cell culture model; mycophenolic acid; norovirus; noroviruses; ribavirin

Mesh:

Substances:

Year:  2017        PMID: 28807916      PMCID: PMC5655111          DOI: 10.1128/AAC.01095-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  46 in total

1.  Calicivirus enteritis in an intestinal transplant recipient.

Authors:  Stuart S Kaufman; Nando K Chatterjee; Meghan E Fuschino; Margret S Magid; Ronald E Gordon; Dale L Morse; Betsy C Herold; Neal S LeLeiko; Allan Tschernia; Sander S Florman; Gabriel E Gondolesi; Thomas M Fishbein
Journal:  Am J Transplant       Date:  2003-06       Impact factor: 8.086

2.  Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient.

Authors:  N Boillat Blanco; R Kuonen; C Bellini; O Manuel; C Estrade; J Mazza-Stalder; J D Aubert; R Sahli; P Meylan
Journal:  Transpl Infect Dis       Date:  2010-08-30       Impact factor: 2.228

3.  Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients?

Authors:  Diana F Florescu; Elizabeth D Hermsen; Joong Y Kwon; Dalal Gumeel; Wendy J Grant; David F Mercer; Andre C Kalil
Journal:  Pediatr Transplant       Date:  2011-08-23

4.  The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency.

Authors:  Jeremy M Woodward; Effrossyni Gkrania-Klotsas; Anthony Yk Cordero-Ng; Aloysious Aravinthan; Betty N Bandoh; Hongxiang Liu; Susan Davies; Hongyi Zhang; Philip Stevenson; Martin D Curran; Dinakantha Kumararatne
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

5.  Chronic norovirus infection in renal transplant recipients.

Authors:  Timm H Westhoff; Maria Vergoulidou; Christoph Loddenkemper; Stefan Schwartz; Jörg Hofmann; Thomas Schneider; Walter Zidek; Markus van der Giet
Journal:  Nephrol Dial Transplant       Date:  2008-12-10       Impact factor: 5.992

6.  Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.

Authors:  Kyeong-Ok Chang; David W George
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

7.  The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model.

Authors:  Joana Rocha-Pereira; Dirk Jochmans; Yannick Debing; Erik Verbeken; Maria S J Nascimento; Johan Neyts
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

8.  Characterization of human type I and type II IMP dehydrogenases.

Authors:  S F Carr; E Papp; J C Wu; Y Natsumeda
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

9.  Murine norovirus (MNV-1) exposure in vitro to the purine nucleoside analog Ribavirin increases quasispecies diversity.

Authors:  Timothy R Julian; Joseph D Baugher; Christine M Rippinger; Rebecca Pinekenstein; Abimbola O Kolawole; Thomas S Mehoke; Christiane E Wobus; Andrew B Feldman; Fernando J Pineda; Kellogg J Schwab
Journal:  Virus Res       Date:  2015-10-19       Impact factor: 3.303

10.  Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia.

Authors:  Casey L McAtee; Rachel Webman; Robert H Gilman; Carolina Mejia; Caryn Bern; Sonia Apaza; Susan Espetia; Mónica Pajuelo; Mayuko Saito; Roxanna Challappa; Richard Soria; Jose P Ribera; Daniel Lozano; Faustino Torrico
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

View more
  10 in total

1.  The IMPDH inhibitors, ribavirin and mycophenolic acid, inhibit peste des petits ruminants virus infection.

Authors:  Qiu-Yan Chang; Fu-Cheng Guo; Xue-Rui Li; Jian-Hua Zhou; Xuepeng Cai; Qiuwei Pan; Xiao-Xia Ma
Journal:  Vet Res Commun       Date:  2018-08-09       Impact factor: 2.459

2.  The Cyclophilin-Dependent Calcineurin Inhibitor Voclosporin Inhibits SARS-CoV-2 Replication in Cell Culture.

Authors:  Natacha S Ogando; Erik Metscher; Dirk Jan A R Moes; Eline J Arends; Ali Tas; Jennifer Cross; Eric J Snijder; Y K Onno Teng; Aiko P J de Vries; Martijn J van Hemert
Journal:  Transpl Int       Date:  2022-06-24       Impact factor: 3.842

3.  Antiviral activity of ribavirin and favipiravir against human astroviruses.

Authors:  Andrew B Janowski; Holly Dudley; David Wang
Journal:  J Clin Virol       Date:  2019-12-17       Impact factor: 3.168

4.  Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.

Authors:  Lei Xu; Buyun Ma; Wen Dang; Sunrui Chen; Yuebang Yin; Kyeong-Ok Chang; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

5.  IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.

Authors:  Shiyu Duan; Wenqing Huang; Xiaoting Liu; Xuming Liu; Nana Chen; Qiong Xu; Yukun Hu; Wen Song; Jun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2018-12-05

6.  SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.

Authors:  Michela Zaffagni; Jenna M Harris; Ines L Patop; Nagarjuna Reddy Pamudurti; Sinead Nguyen; Sebastian Kadener
Journal:  Elife       Date:  2022-03-16       Impact factor: 8.713

Review 7.  Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy.

Authors:  Claudia Soledad Sepúlveda; Cybele Carina García; Elsa Beatriz Damonte
Journal:  Microorganisms       Date:  2022-08-12

8.  SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.

Authors:  Tai-Wei Li; Adam D Kenney; Jun-Gyu Park; Guillaume N Fiches; Helu Liu; Dawei Zhou; Ayan Biswas; Weiqiang Zhao; Jianwen Que; Netty Santoso; Luis Martinez-Sobrido; Jacob S Yount; Jian Zhu
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

9.  SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation.

Authors:  Taiwei Li; Adam D Kenney; Helu Liu; Guillaume N Fiches; Dawei Zhou; Ayan Biswas; Jianwen Que; Netty Santoso; Jacob S Yount; Jian Zhu
Journal:  bioRxiv       Date:  2021-05-26

10.  2'-Fluoro-2'-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705.

Authors:  Peifa Yu; Yining Wang; Yunlong Li; Yang Li; Zhijiang Miao; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Arch Virol       Date:  2020-08-08       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.